Biologics
-
Biologics
Bioventus Forges National Contract With UnitedHealthcare Commercial Plans
The contract gives members access to DUROLANE and GELSYN-3 for knee osteoarthritis.Bioventus 09.09.19
-
Biologics
Agilon Bone Grafting Solution Launched by Biogennix
The material is fully biocompatible with human bone.Biogennix 09.06.19
-
Biologics
Upsurge in Prevalence of Sports Injuries to Improve Bone Void Fillers Penetration Through 2028
In Europe, a majority of sports injuries have been leading to bone fractures, creating significantly high demand for bone void fillers.Persistence Market Research 08.30.19
-
Biologics
Cerapedics Expands its Headquarters
Company adds 10,000 square feet and doubles employee headcount at Denver metropolitan base.Cerapedics 08.29.19
-
3-D Printing/Additive Mfg. | Biologics
Bioprinting Complex Living Tissue in Just a Few Seconds
Examples of the researchers' work include a valve similar to a heart valve, a meniscus, and a complex-shaped part of the femur.Videos Ecole Polytechnique Federale de Lausanne 08.23.19
-
Biologics | Bracing/Prosthetics | Extremities | Imaging | Instruments | Large Joint | MIS/Robotics | Spine/Neurology | Trauma/Sports
The 2019 Top 10 Global Orthopedic Device Firms
Robotics and M&A continued to define the orthopedics industry in 2018.ODT Staff 08.14.19
-
Biologics
Bioventus Launches DUROLANE SJ (1mL) in Australia and New Zealand
Company also receives expanded indications for DUROLANE (3mL).Bioventus 08.14.19
-
Biologics
New Academic Delphi Panel Formed to Define Best Practices for Using Bone Marrow Concentrate
Nationwide panel is using the Delphi consensus building method to drive consensus and guidelines on the procedural use of bone marrow concentrate.Academic Delphi Panel 08.13.19
-
Biologics
OssDsign AB Further Strengthens its Patent Portfolio
Newest additions are related to the company's material technology and implant design.OssDsign AB 07.22.19
-
Biologics
SeaSpine Expands Portfolio of OsteoStrand and OsteoStrand Plus Demineralized Bone Fibers
The first OsteoStrand Plus implantations were conducted in Maryland.Globe Newswire 07.19.19
-
Biologics | Materials
New Hydrogel Could Help Regenerate Cartilage
Polymer material has the capacity to generate the appropriate niche for growth in a number of chondrocytes.University of Granada 07.10.19
-
Biologics
Anika Appoints Executive Vice President of Business Development and Strategic Planning
Industry veteran brings extensive experience leading business development groups.Business Wire 07.09.19
-
Biologics
NanoFUSE Biologics Continues Global Expansion With Launch in Thailand
Thailand is one of the fastest aging countries in Asia and is well-known for medical tourism.PR Newswire 07.08.19
-
Biologics | Spine/Neurology
Celling Spine Buys Link Spine
With this acquisition, Celling intends to further develop and promote a cell-centric spine platform.PR Newswire 07.02.19
-
Biologics
Private Equity Firm Purchases Axolotl Biologix
Company plans to initiate clinical trials and FDA product approvals.Axolotl Biologix Inc. 06.27.19
-
Biologics
Demand for User-friendly, Versatile Bone Growth Stimulators to Create Multiple Market Opportunities
The global bone growth stimulators market is expected to account for $1.38 billion by the end of 2029, research shows.Future Market Insights 06.26.19
-
Biologics
Cerapedics Appoints Vice President of Clinical and Market Development
New hire most recently served as director of Market Development for Spinal Kinetics, an Orthofix Company.PR Newswire 06.25.19
-
Biologics | Materials
Hydrogel Offers Double Punch Against Bone Infections
Hydrogel showed reduction in Staphylococcus aureus infection—a common infection in orthopedic surgery—along with regeneration within large bone defects.Georgia Tech 06.24.19
-
Biologics
Study: Regulations Limit Orthopedic Biomaterials Across U.S., European Markets
Biomaterials increasingly are becoming popular with patients who want to avoid surgical implantation of permanent devices or hardware.Business Wire 06.18.19
-
Biologics | Trauma/Sports
Ortho RTi Welcomes New CEO
Claude LeDuc has spent 22 years in the musculoskeletal market, having occupied senior positions with Genzyme, Biomatrix, Serono, and BioSyntech.PR Newswire 06.17.19
follow us
Latest Breaking News From Nutraceuticals World
GOED Opens Registration for Omega-3 Conference in BarcelonaBotanical Program Reviews Analytical Methods to Verify Saw Palmetto
NSF International Promotes David Trosin to Manage Supplement Certification
Latest Breaking News From Coatings World
Jotun Launches New TankFast SolutionConductive Inks Conference to Examine Flexible Electronics, Sensors and More
BASF Opens New Research Lab for Pigments
Latest Breaking News From Medical Product Outsourcing
FDA Clears Artis icono Family of Angiography SystemsSaluda Medical Launches Evoke Commercially in Europe
Conductive Ink Conference to Examine Inks, Flexible Electronics, Sensors, and More
Latest Breaking News From Contract Pharma
GE Healthcare and Germfree to Advance Manufacturing of Novel BiotherapeuticsCatalent, Acura Enter Clinical Manufacturing Pact
Source BioScience Expands Ireland Facility
Latest Breaking News From Beauty Packaging
Conductive Ink Conference to Examine Inks, Flexible Electronics, Sensors and MoreIpsy Recruits Ciara as Brand Ambassador
Influenster Announces its 2019 Reviewers' Choice Award Winners
Latest Breaking News From Happi
Goldstein Named President, L’Oréal Paris USASplat Partners with Borderlands 3
IFF Celebrates Opening of Innovation Center in NJ
Latest Breaking News From Ink World
BASF Opens New Research Lab for PigmentsPhoseon Technology Launches FirePower FP401
IMI Europe Announces Digital Printing Conference 2019 Program
Latest Breaking News From Label & Narrow Web
Sun Chemical and Epple partner on food-safe inksSchreiner MediPharm launches first-opening indicator for prefilled syringes
Electronic and Conductive Inks Conference heads to Oakbrook, IL
Latest Breaking News From Nonwovens Industry
Smithers Unifies BrandsCalifornia Takes No Action on Plastics Prior to Adjournment
Sandler Starts Construction in Perry
